What We Do

IDRI is a Seattle-based not-for-profit organization committed to applying innovative science to the research and development of products to prevent, detect and treat infectious diseases of poverty. 

By integrating capabilities, IDRI strives to create an efficient pathway to bring scientific innovation from the lab to the people who need it most.

NEW! Watch a video highlighting
Washington State's Global Health Impact (Flash required)
produced by 
Washington Global Health Alliance


  IDRI is a member of
  

 




    

IDRI Awarded $314, 500 Grant from Murdock Trust to Expand TB Drug Discovery Program
Seattle, June 25, 2009 - This new funding will support IDRI's efforts to better understand the mechanisms of TB and ultimately identify new drugs to treat it.


IDRI Makes its Adjuvant Available to Increase Global Supply of Pandemic Vaccines
Seattle, June 11, 2009 - Following the World Health Organization (WHO) declaration of swine flu pandemic, IDRI today announced it has successfully developed an adjuvant that could significantly enhance both the effectiveness and supplies of pandemic flu vaccines.
 

Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys
PNAS 
published online before print February 2, 2009